Commercial Manufacturing Services

Commercial Manufacturing Services
Product Description

Certified by the Medicines and Healthcare Products Regulatory Authority (MHRA), we have licences for the manufacture of medicines, controlled drugs, specials and Investigational Medicinal Products (IMPs) in a wide range of formulations including solid dose, powders and hard gel capsules.

We do this for existing and new formulations, for branded and generic pharmaceuticals, and can provide innovative solutions for hard-to-manufacture, niche products.

Our adaptable primary packaging lines offer clinical, commercial or stability blister and bottle packaging.

Technology transfer

Scale up.

Process validation

Product & process remediation and troubleshooting

Bottle and blister packing

Tamper evidence and serialisation

4000m2 packaging facility

1,700 m2 temperature monitored warehouse

1 billion tablets / year

150 million capsules / year

Custom Pharma Services

  • GB
  • 2016
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Specifications
  • Selling Points
    Product Features; Quality Service
  • Supplied from
    United Kingdom

Custom Pharma Services

  • GB
  • 2016
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer

More Products from Custom Pharma Services (1)

  • Clinical And Product Development Services

    Product Clinical And Product Development Services

    Pre-formulation Development
    Drugs are seldom administered to patients as pure compounds, instead they are formulated into medicinal products: but many that start their development journey don’t make it to market, failing for a variety of reasons from inefficacy or toxicity to commercial or manufac...

Custom Pharma Services resources (1)

  • News Custom Pharma Services goes Back to the Future!

    Whilst investing in modern technologies, Custom Pharma Services is using our decades of experience and expertise in the lifecycle management of niche and difficult to manufacture medicines to accelerate the development of new and novel medicines for our clients.